Pharmaceuticals (Mar 2023)

Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications

  • Elham Assadpour,
  • Atefe Rezaei,
  • Sabya Sachi Das,
  • Balaga Venkata Krishna Rao,
  • Sandeep Kumar Singh,
  • Mohammad Saeed Kharazmi,
  • Niraj Kumar Jha,
  • Saurabh Kumar Jha,
  • Miguel A. Prieto,
  • Seid Mahdi Jafari

DOI
https://doi.org/10.3390/ph16040487
Journal volume & issue
Vol. 16, no. 4
p. 487

Abstract

Read online

Cannabidiol (CBD), one of the most promising constituents isolated from Cannabis sativa, exhibits diverse pharmacological actions. However, the applications of CBD are restricted mainly due to its poor oral bioavailability. Therefore, researchers are focusing on the development of novel strategies for the effective delivery of CBD with improved oral bioavailability. In this context, researchers have designed nanocarriers to overcome limitations associated with CBD. The CBD-loaded nanocarriers assist in improving the therapeutic efficacy, targetability, and controlled biodistribution of CBD with negligible toxicity for treating various disease conditions. In this review, we have summarized and discussed various molecular targets, targeting mechanisms and types of nanocarrier-based delivery systems associated with CBD for the effective management of various disease conditions. This strategic information will help researchers in the establishment of novel nanotechnology interventions for targeting CBD.

Keywords